PT1492501E - Métodos de uso de corpos lamelares para propósitos terapêuticos - Google Patents

Métodos de uso de corpos lamelares para propósitos terapêuticos Download PDF

Info

Publication number
PT1492501E
PT1492501E PT03722717T PT03722717T PT1492501E PT 1492501 E PT1492501 E PT 1492501E PT 03722717 T PT03722717 T PT 03722717T PT 03722717 T PT03722717 T PT 03722717T PT 1492501 E PT1492501 E PT 1492501E
Authority
PT
Portugal
Prior art keywords
methods
therapeutic purposes
lamellar bodies
lamellar
bodies
Prior art date
Application number
PT03722717T
Other languages
English (en)
Inventor
James Dobbie
Original Assignee
Lamellar Biomedical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lamellar Biomedical Ltd filed Critical Lamellar Biomedical Ltd
Publication of PT1492501E publication Critical patent/PT1492501E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/688—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols both hydroxy compounds having nitrogen atoms, e.g. sphingomyelins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Dispersion Chemistry (AREA)
  • Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
PT03722717T 2002-04-03 2003-04-02 Métodos de uso de corpos lamelares para propósitos terapêuticos PT1492501E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0207653.7A GB0207653D0 (en) 2002-04-03 2002-04-03 Methods of using lamellar bodies for therapeutic purposes

Publications (1)

Publication Number Publication Date
PT1492501E true PT1492501E (pt) 2009-03-26

Family

ID=9934144

Family Applications (1)

Application Number Title Priority Date Filing Date
PT03722717T PT1492501E (pt) 2002-04-03 2003-04-02 Métodos de uso de corpos lamelares para propósitos terapêuticos

Country Status (11)

Country Link
US (1) US7906139B2 (pt)
EP (2) EP2177212B1 (pt)
JP (1) JP4657608B2 (pt)
AT (1) ATE416756T1 (pt)
AU (1) AU2003229881A1 (pt)
DE (1) DE60325194D1 (pt)
DK (1) DK1492501T3 (pt)
ES (2) ES2319276T3 (pt)
GB (1) GB0207653D0 (pt)
PT (1) PT1492501E (pt)
WO (1) WO2003082245A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0007150D0 (en) * 2000-03-24 2000-05-17 Lamellar Therapeutics Limited Immunotherapeutic methods and compositions
CA2540328C (en) * 2003-09-25 2012-11-20 Lamellar Therapeutics Limited Compositions and methods of using lamellar bodies for therapeutic purposes
GB0322448D0 (en) 2003-09-25 2003-10-29 Lamellar Therapeutics Ltd Using lamellar bodies to modify linear biological macro molecules
US9119901B2 (en) 2005-04-28 2015-09-01 Warsaw Orthopedic, Inc. Surface treatments for promoting selective tissue attachment to medical impants
US8414907B2 (en) 2005-04-28 2013-04-09 Warsaw Orthopedic, Inc. Coatings on medical implants to guide soft tissue healing
WO2008019048A1 (en) * 2006-08-04 2008-02-14 Meditrina Pharmaceuticals Use of aromatase inhibitors for thining the endometrium or treating menorrhagia
FR2921253B1 (fr) * 2007-09-26 2012-11-16 Lvmh Rech Composition cosmetique sous la forme d'une emulsion comprenant une phase aqueuse continue et une phase grasse dispersee et son procede de preparation
DE102008005172A1 (de) * 2008-01-19 2009-07-23 Mike Ehrlich Pharmazeutische Zusammensetzung zur Verhinderung von post-operativen Adhäsionen
EP2282723A2 (en) * 2008-03-26 2011-02-16 University of Oxford Endoplasmic reticulum targeting liposomes
WO2015200355A1 (en) * 2014-06-24 2015-12-30 Saint Louis University Methods for reducing fibrosis induced by peritoneal dialysis
EP3692376A1 (en) * 2017-10-06 2020-08-12 Sime Diagnostics Ltd. Lamellar body purification for diagnosis and treatment of a disease or disorder
US20210145741A1 (en) * 2018-04-17 2021-05-20 Lamellar Biomedical Limited Antifibrotic composition

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5925375A (en) * 1987-05-22 1999-07-20 The Liposome Company, Inc. Therapeutic use of multilamellar liposomal prostaglandin formulations
US5403592A (en) * 1987-08-25 1995-04-04 Macnaught Pty Limited Lubricant composition for rheumatism
JPH01295933A (ja) 1989-03-25 1989-11-29 Toto Ltd 衛生洗浄装置
JPH02295933A (ja) * 1989-05-10 1990-12-06 Wakamoto Pharmaceut Co Ltd 封入純度の高いプラスミノーゲン活性化因子封入リポソームの製造法
WO1991012026A1 (en) * 1990-02-14 1991-08-22 Macnaught Pty Limited Means of reducing surgical adhesions
EP0721328A4 (en) * 1993-09-27 1997-09-17 Smithkline Beecham Corp CAMPTOTHECIN FORMULATIONS
US5462752A (en) * 1994-07-28 1995-10-31 Prp, Inc. Inhibition of platelet binding
US6080422A (en) * 1995-10-11 2000-06-27 Talaria Therapeutics, Inc. Methods of angioplasty and cardiac catheterization
AU7685798A (en) * 1997-05-29 1998-12-30 Applied Biotechnologies Inc. Compositions and methods for preventing adhesion
SE9702698D0 (sv) * 1997-07-14 1997-07-14 Stig Bengmark Compositions for lubricating and separating tissues and biological membranes
GB9807298D0 (en) * 1998-04-03 1998-06-03 Britannia Pharmaceuticals Ltd Medicament
US6193997B1 (en) * 1998-09-27 2001-02-27 Generex Pharmaceuticals Inc. Proteinic drug delivery system using membrane mimetics
JP2003508349A (ja) * 1999-05-14 2003-03-04 エスペリオン エルユーブイ ディベロップメント， インコーポレイテッド アンギナおよび／またはアンギナ等価状態を処置する方法、ならびにそれに関連する薬学的組成物およびキット
GB0007150D0 (en) * 2000-03-24 2000-05-17 Lamellar Therapeutics Limited Immunotherapeutic methods and compositions
CA2319928A1 (en) * 2000-09-18 2002-03-18 Vasogen Ireland Limited Apoptosis-mimicking synthetic entities and use thereof in medical treatments

Also Published As

Publication number Publication date
EP1492501A1 (en) 2005-01-05
JP2005526101A (ja) 2005-09-02
ES2409757T3 (es) 2013-06-27
ES2319276T3 (es) 2009-05-06
ATE416756T1 (de) 2008-12-15
EP1492501B1 (en) 2008-12-10
EP2177212B1 (en) 2013-03-06
WO2003082245A1 (en) 2003-10-09
EP2177212A1 (en) 2010-04-21
DE60325194D1 (de) 2009-01-22
JP4657608B2 (ja) 2011-03-23
GB0207653D0 (en) 2002-05-15
US20040126420A1 (en) 2004-07-01
DK1492501T3 (da) 2009-04-06
AU2003229881A1 (en) 2003-10-13
US7906139B2 (en) 2011-03-15

Similar Documents

Publication Publication Date Title
SG149063A1 (en) Use of modified cyclosporins for the treatment of hcv disorders
EP1613308A4 (en) CANCER TREATMENT METHODS
AU2003286567A8 (en) Methods for the treatment of skin disorders
IL188249A0 (en) Cephalosporin related compounds for use in therapy
PL372425A1 (en) Dihydrobenzodiazepin-2-one-derivatives for the treatment of neurological disorders
HUS2200036I1 (hu) Dihidroimidazolonok alkalmazása kutyák kezelésére
GB0329874D0 (en) Compounds useful for the treatment of diseases
AU2003258145A8 (en) Substituted phenylindoles for the treatment of hiv
PL377552A1 (pl) Leczenie zespołu nadpobudliwości psychoruchowej z deficytem uwagi
EP1611120A4 (en) NEW M THODES FOR THE TREATMENT OF INFLAMMATORY DISEASES
GB0207653D0 (en) Methods of using lamellar bodies for therapeutic purposes
TW200510398A (en) Novel compounds
GB0213869D0 (en) The treatment of pain
IL162154A0 (en) Prostagandin composition for the treatment of erectile dysfunction
IL162818A0 (en) Combination therapy for the treatment of bacterialinfections
AU2003230004A8 (en) Methods of therapy for inducing tolerance
GB0201025D0 (en) The treatment of degenerative diseases
GB0217493D0 (en) Novel methods of treatment
AU2003240174A8 (en) Compositions for the treatment of edematous-firbrosclerotic panniculopathy
HUP0500698A2 (en) Use of an ascomycin for the treatment of blepharitis
IL175611A0 (en) Combinations for the treatment of proliferative diseases
YU51802A (sh) Nova terapeutska primena enoksaparina
GB0216097D0 (en) Treatment of proliferative disorders
GB0325957D0 (en) The treatment of pain
GB0221557D0 (en) The treatment of IBD